Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
Registration is now open for RAPS Euro Convergence 2021! Attend to join peers from EU and around the world to gain insights and exchange ideas on the regions most pressing issues.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 15 July 2016 | By Zachary Brennan
As part of the 14th round of ongoing negotiations of the Transatlantic Trade Investment Partnership (TTIP) between the US and EU, the European Commission has released a new proposal that would push for more collaboration on medical device regulations.
The text of the proposal discusses some of the high-level themes of what both sides would to like find more common ground on, including the convergence of technical and clinical requirements applicable to devices; removing unnecessary duplications of data submission and device testing and to avoid duplicative inspections of manufacturing sites; to promote the convergence of device standards; and to promote existing multilateral and bilateral regulatory cooperation related to devices.
In addition to recognizing the importance of collaborating as part of other device-related international organizations – like the International Medical Devices Regulators Forum (IMDRF), the International Organisation for Standardisation (ISO), the International Electrotechnical Commission (IEC) and the Global Medical Device Nomenclature (GMDN) – the text focuses on:
Specifics
A number of the details offered focus on consistency and collaboration via IMDRF. For instance, in order to ensure the interoperability of UDI databases, the text calls on both US and EU regulators to develop their databases in line with the guidance adopted by IMDRF.
“For that purpose, each Party shall promote the use of a common format for data exchange between unique device identification databases, and take into account relevant specifications and semantic standards existing in the area,” the text reads.
The proposal also focuses on ensuring that US and EU authorities can exchange regulatory information, including confidential and trade secret information related to conformity assessment, approval and the supervision of devices, though it also says neither side will publicly disclose such confidential information of commercial, technical or scientific nature, including trade secrets not in the public domain.
“The regulatory cooperation between the responsible authorities of the Parties shall be guided by a joint regulatory cooperation work plan which sets out short and medium term priorities for regulatory cooperation under this Annex,” the text adds.
The proposal on devices comes two months after a similar proposal around convergence of EU and US pharmaceutical regulations.
EU PROPOSAL FOR AN ANNEX ON MEDICAL DEVICES
EU negotiating texts in TTIP
Tags: UDIs, device regulations, medical devices in EU and US, TTIP
Regulatory Focus newsletters
All the biggest regulatory news and happenings.